32
Participants
Start Date
January 22, 2019
Primary Completion Date
March 31, 2020
Study Completion Date
March 31, 2020
MetFORMIN Hydrochloride ER
Subjects will be exposed to 500mg, 1000mg, or 1500mg of daily ER Metformin, by mouth, for up to 90 days. Subjects will have their venous blood sampled and baseline, throughout the trial, and following completion of their metformin exposure.
Placebo
Subjects will be exposed to placebo, by mouth, for up to 90 days. Subjects will have their venous blood sampled and baseline, throughout the trial, and following completion of their metformin exposure.
University of Pittsburgh Medical Center, Pittsburgh
Brian Zuckerbraun
OTHER